The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19
NCT04291053
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
550
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Huaier Granule
Sponsor
Tongji Hospital